LYRA
Price
$12.30
Change
-$0.56 (-4.35%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
16.3M
47 days until earnings call
OGEN
Price
$3.63
Change
+$0.02 (+0.55%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
2.48M
Interact to see
Advertisement

LYRA vs OGEN

Header iconLYRA vs OGEN Comparison
Open Charts LYRA vs OGENBanner chart's image
Lyra Therapeutics
Price$12.30
Change-$0.56 (-4.35%)
VolumeN/A
Capitalization16.3M
Oragenics
Price$3.63
Change+$0.02 (+0.55%)
VolumeN/A
Capitalization2.48M
LYRA vs OGEN Comparison Chart in %
Loading...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYRA vs. OGEN commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRA is a Buy and OGEN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (LYRA: $12.86 vs. OGEN: $3.61)
Brand notoriety: LYRA and OGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYRA: 14% vs. OGEN: 16%
Market capitalization -- LYRA: $16.3M vs. OGEN: $2.48M
LYRA [@Biotechnology] is valued at $16.3M. OGEN’s [@Biotechnology] market capitalization is $2.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYRA’s FA Score shows that 0 FA rating(s) are green whileOGEN’s FA Score has 0 green FA rating(s).

  • LYRA’s FA Score: 0 green, 5 red.
  • OGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, LYRA is a better buy in the long-term than OGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYRA’s TA Score shows that 5 TA indicator(s) are bullish while OGEN’s TA Score has 4 bullish TA indicator(s).

  • LYRA’s TA Score: 5 bullish, 5 bearish.
  • OGEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, OGEN is a better buy in the short-term than LYRA.

Price Growth

LYRA (@Biotechnology) experienced а +25.10% price change this week, while OGEN (@Biotechnology) price change was -17.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

LYRA is expected to report earnings on Aug 12, 2025.

OGEN is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LYRA($16.3M) has a higher market cap than OGEN($2.48M). LYRA YTD gains are higher at: 24.612 vs. OGEN (-67.416). OGEN has higher annual earnings (EBITDA): -10.11M vs. LYRA (-44.7M). LYRA has more cash in the bank: 31.7M vs. OGEN (3.42M). OGEN has less debt than LYRA: OGEN (2.55M) vs LYRA (33.4M). LYRA has higher revenues than OGEN: LYRA (1.19M) vs OGEN (0).
LYRAOGENLYRA / OGEN
Capitalization16.3M2.48M658%
EBITDA-44.7M-10.11M442%
Gain YTD24.612-67.416-37%
P/E RatioN/AN/A-
Revenue1.19M0-
Total Cash31.7M3.42M927%
Total Debt33.4M2.55M1,308%
FUNDAMENTALS RATINGS
OGEN: Fundamental Ratings
OGEN
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYRAOGEN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRKR1.440.02
+1.41%
Marker Therapeutics
CRGX4.180.05
+1.21%
CARGO Therapeutics
EVRI14.23N/A
N/A
Everi Holdings
INVH33.83-0.19
-0.56%
Invitation Homes
OSCR20.02-0.40
-1.96%
Oscar Health

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with ATHA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then ATHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
+1.40%
ATHA - OGEN
44%
Loosely correlated
+0.68%
REVB - OGEN
36%
Loosely correlated
+12.40%
SRPT - OGEN
30%
Poorly correlated
+0.58%
LYRA - OGEN
28%
Poorly correlated
+11.92%
CHRS - OGEN
27%
Poorly correlated
+5.64%
More